Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Assessment of the reproducibility of oligoclonal IgM band detection for its application in daily clinical practice.
Pre-existing T- and B-cell defects in one progressive multifocal leukoencephalopathy patient.
Reduced R2' in multiple sclerosis normal appearing white matter and lesions may reflect decreased myelin and iron content.
Systematic localization of common disease-associated variation in regulatory DNA.
Th17 Cells in Neuromyelitis Optica Spectrum Disorder: A review.
Role of adenosine in oligodendrocyte precursor maturation.
Fingolimod-Associated Peripheral Vascular Adverse Effects.
Time to secondary progression in patients with multiple sclerosis who were treated with first generation immunomodulating drugs.
Simvastatin inhibits IL-17 secretion by targeting multiple IL-17-regulatory cytokines and by inhibiting the expression of IL-17 transcription factor RORC in CD4+ lymphocytes.
Riluzole.
Humoral mechanisms in T cell vaccination: induction and functional characterization of anti-lymphocytic autoantibodies.
Where Do AQP4 Antibodies Fit in the Pathogenesis of NMO?
Vitamin d and multiple sclerosis.
Feedforward postural control in individuals with multiple sclerosis during load release.
Orbital Doppler evaluation of blood flow velocities in optic neuritis.
Callosal atrophy in multiple sclerosis is related to cognitive speed.
[Optic neuritis: diagnosis, treatment and clinical implications].
Influence of yoga and aerobics exercise on fatigue, pain and psychosocial status in patients with multiple sclerosis: A Randomized Trial.
Novel immunoregulatory properties of EGCG on reducing inflammation in EAE.
Cortical pathology in multiple sclerosis: experimental approaches to studies on the mechanisms of demyelination and remyelination.
Treatment of the chronic progressive form of multiple sclerosis with a combination of cyclophosphamide and prednisone.
Atacicept in multiple sclerosis (ATAMS): a randomised, placebo-controlled, double-blind, phase 2 trial.
Increased oligodendrogenesis by humanin promotes axonal remyelination and neurological recovery in hypoxic/ischemic brains.
Psychological effects of calisthenic exercises on neuroinflammatory and rheumatic diseases.
Pages
« first
‹ previous
…
224
225
226
227
228
229
230
231
232
…
next ›
last »